European Medicines Agency (EMEA) consensus on the classification of the primary systemic vasculitides (PSV) for epidemiological studies

SE Lane; RA Watts; DGI Scott

European Medicines Agency (EMEA) consensus on the classification of the primary systemic vasculitides (PSV) for epidemiological studies

SE Lane, RA Watts, DGI Scott

Research output: Contribution to conference › Paper

Original language	English
Pages	I22-I22 Suppl. 1
Publication status	Published - Mar 2005
Event	Joint Meeting of the British Society for Rheumatology/Deutsche Gesellschaft fur Rheumatologie and Spring Meeting of the British Health Professionals in Rheumatology - Birmingham, United Kingdom Duration: 19 Apr 2005 → 22 Apr 2005

Conference

Conference	Joint Meeting of the British Society for Rheumatology/Deutsche Gesellschaft fur Rheumatologie and Spring Meeting of the British Health Professionals in Rheumatology
Country/Territory	United Kingdom
City	Birmingham
Period	19/04/05 → 22/04/05

Cite this

Lane, SE., Watts, RA., & Scott, DGI. (2005). European Medicines Agency (EMEA) consensus on the classification of the primary systemic vasculitides (PSV) for epidemiological studies. I22-I22 Suppl. 1. Paper presented at Joint Meeting of the British Society for Rheumatology/Deutsche Gesellschaft fur Rheumatologie and Spring Meeting of the British Health Professionals in Rheumatology, Birmingham, United Kingdom.

Lane, SE ; Watts, RA ; Scott, DGI. / European Medicines Agency (EMEA) consensus on the classification of the primary systemic vasculitides (PSV) for epidemiological studies. Paper presented at Joint Meeting of the British Society for Rheumatology/Deutsche Gesellschaft fur Rheumatologie and Spring Meeting of the British Health Professionals in Rheumatology, Birmingham, United Kingdom.

@conference{f9ae242b5b0e454da25a29347d7dd97d,

title = "European Medicines Agency (EMEA) consensus on the classification of the primary systemic vasculitides (PSV) for epidemiological studies",

author = "SE Lane and RA Watts and DGI Scott",

year = "2005",

month = mar,

language = "English",

pages = "I22--I22 Suppl. 1",

note = "Joint Meeting of the British Society for Rheumatology/Deutsche Gesellschaft fur Rheumatologie and Spring Meeting of the British Health Professionals in Rheumatology ; Conference date: 19-04-2005 Through 22-04-2005",

}

Lane, SE, Watts, RA & Scott, DGI 2005, 'European Medicines Agency (EMEA) consensus on the classification of the primary systemic vasculitides (PSV) for epidemiological studies', Paper presented at Joint Meeting of the British Society for Rheumatology/Deutsche Gesellschaft fur Rheumatologie and Spring Meeting of the British Health Professionals in Rheumatology, Birmingham, United Kingdom, 19/04/05 - 22/04/05 pp. I22-I22 Suppl. 1.

European Medicines Agency (EMEA) consensus on the classification of the primary systemic vasculitides (PSV) for epidemiological studies. / Lane, SE; Watts, RA; Scott, DGI.

2005. I22-I22 Suppl. 1 Paper presented at Joint Meeting of the British Society for Rheumatology/Deutsche Gesellschaft fur Rheumatologie and Spring Meeting of the British Health Professionals in Rheumatology, Birmingham, United Kingdom.

Research output: Contribution to conference › Paper

TY - CONF

T1 - European Medicines Agency (EMEA) consensus on the classification of the primary systemic vasculitides (PSV) for epidemiological studies

AU - Lane, SE

AU - Watts, RA

AU - Scott, DGI

PY - 2005/3

Y1 - 2005/3

M3 - Paper

SP - I22-I22 Suppl. 1

T2 - Joint Meeting of the British Society for Rheumatology/Deutsche Gesellschaft fur Rheumatologie and Spring Meeting of the British Health Professionals in Rheumatology

Y2 - 19 April 2005 through 22 April 2005

ER -

Lane SE, Watts RA, Scott DGI. European Medicines Agency (EMEA) consensus on the classification of the primary systemic vasculitides (PSV) for epidemiological studies. 2005. Paper presented at Joint Meeting of the British Society for Rheumatology/Deutsche Gesellschaft fur Rheumatologie and Spring Meeting of the British Health Professionals in Rheumatology, Birmingham, United Kingdom.